13D Filing: James E. Flynn and DFB Healthcare Acquisitions Corp.

This Amendment No. 1 (this “Amendment”) to
Schedule 13D amends the Schedule 13D (“Schedule 13D”) filed by (i) Deerfield Mgmt IV, L.P. (“Deerfield
Mgmt IV”), (ii) Deerfield Private Design Fund IV, L.P. (“Deerfield Private Design Fund IV”), (iii)
Deerfield Management Company, L.P. (“Deerfield Management”), (iv) James E. Flynn, a natural person (“Flynn”),
and (v) Steven I. Hochberg, a natural person (“Hochberg” and collectively with Deerfield Mgmt IV, Deerfield
Private Design Fund IV, Deerfield Management and Flynn, the “Reporting Persons”), with respect to shares of
common stock, par value $0.0001 per share (the “Common Stock”) of DFB Healthcare Acquisitions Corp (the “Company”).
Capitalized terms used but not otherwise defined in this Amendment have the meanings ascribed to them in the Schedule 13D.

Item
4. Purpose of Transaction.

Pursuant to the Letter Agreement, up to 921,848 and 3,913 of
the Founder Shares held by the Sponsor and Hochberg, respectively, were subject to forfeiture depending upon the extent to which
the Underwriters exercised their over-allotment option in connection with the IPO. The Underwriters’ over-allotment option
expired unexercised on April 2, 2018 and, accordingly, the Sponsor and Hochberg subsequently forfeited, for no consideration, 921,848
and 3,913 Founder Shares, respectively.